T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VVC
1701
DELISTED
Vectren Corporation
VVC
| $845K | ﹤0.01% |
25,349
| – | – |
|
|
JNS
1702
DELISTED
Janus Capital Group Inc
JNS
| $842K | ﹤0.01% |
98,900
+12,600
| +15% | +$113K |
|
1703
Crane NXT
CXT
$2.96B
| $841K | ﹤0.01% |
39,272
+4,894
| +14% | +$104K |
|
1704
Charles River Laboratories
CRL
$13.6B
| $840K | ﹤0.01% |
18,168
-2,400
| -12% | -$110K |
|
1705
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $837K | ﹤0.01% |
32,500
+1,900
| +6% | +$49.6K |
|
1706
Webster Financial
WBS
$12.8B
| $833K | ﹤0.01% |
32,613
+4,300
| +15% | +$114K |
|
1707
Prospect Capital
PSEC
$1.16B
| $832K | ﹤0.01% |
74,400
+9,700
| +15% | +$108K |
|
|
IM
1708
DELISTED
Ingram Micro
IM
| $831K | ﹤0.01% |
36,062
+4,300
| +14% | +$94.8K |
|
1709
Huntington Ingalls Industries
HII
$12.8B
| $829K | ﹤0.01% |
12,300
| – | – |
|
|
CTB
1710
DELISTED
Cooper Tire & Rubber Co.
CTB
| $829K | ﹤0.01% |
26,900
-12,700
| -32% | -$414K |
|
|
PL
1711
DELISTED
PROTECTIVE LIFE CORP
PL
| $825K | ﹤0.01% |
19,400
| – | – |
|
1712
Darling Ingredients
DAR
$10.1B
| $823K | ﹤0.01% |
38,900
| – | – |
|
|
UIL
1713
DELISTED
UIL HOLDINGS
UIL
| $818K | ﹤0.01% |
21,999
-3,000
| -12% | -$116K |
|
|
CAB
1714
DELISTED
Cabela's Inc
CAB
| $809K | ﹤0.01% |
12,841
+800
| +7% | +$53.4K |
|
1715
Sarepta Therapeutics
SRPT
$1.96B
| $805K | ﹤0.01% |
17,048
-857,200
| -98% | -$33M |
|
1716
COPT Defense Properties
CDP
$4.23B
| $799K | ﹤0.01% |
34,600
+2,100
| +6% | +$52.4K |
|
|
SGY
1717
DELISTED
Stone Energy
SGY
| $799K | ﹤0.01% |
434
-139
| -24% | -$217K |
|
|
PNY
1718
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $799K | ﹤0.01% |
24,300
| – | – |
|
1719
Manhattan Associates
MANH
$11.4B
| $798K | ﹤0.01% |
33,440
-3,600
| -10% | -$79.4K |
|
1720
SITE Centers
SITC
$158M
| $798K | ﹤0.01% |
39,426
| – | – |
|
1721
Cinemark Holdings
CNK
$4.38B
| $797K | ﹤0.01% |
25,100
| – | – |
|
|
DST
1722
DELISTED
DST Systems Inc.
DST
| $797K | ﹤0.01% |
21,126
| – | – |
|
1723
Upbound Group
UPBD
$1.14B
| $796K | ﹤0.01% |
20,900
-7,200
| -26% | -$278K |
|
1724
iShares MSCI Australia ETF
EWA
$1.46B
| $793K | ﹤0.01% |
31,400
+17,000
| +118% | +$409K |
|
1725
Brink's
BCO
$4.72B
| $791K | ﹤0.01% |
27,940
-5,109
| -15% | -$139K |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.